Active, not recruitingPhase 3NCT06747468
Avexitide for Treatment of Post-Bariatric Hypoglycemia
Studying Disorder of carbohydrate metabolism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Amylyx Pharmaceuticals Inc.
- Principal Investigator
- Amylyx Medical DirectorAmylyx Pharmaceuticals
- Intervention
- Avexitide(drug)
- Enrollment
- 75 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2026
Study locations (21)
- Stanford Health Care - Endocrinology Clinic, Stanford, California, United States
- University of Colorado Health Anschutz Medical Campus, Aurora, Colorado, United States
- East Coast Institute for Research, Jacksonville, Florida, United States
- Hanson Diabetes Center, Port Charlotte, Florida, United States
- Georgia Clincal Research, Lawrenceville, Georgia, United States
- Cotton-O'Neil Diabetes and Endocrinology Center, Topeka, Kansas, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Joslin Diabetes Center, Boston, Massachusetts, United States
- NYC Health + Hospitals/Queens - BRANY, New Hyde Park, New York, United States
- Duke Center for Metabolic and Weight Loss Surgery, Durham, North Carolina, United States
- Centricity Research Morehead City Multispecialty, Morehead City, North Carolina, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Penn Medicine University City, Philadelphia, Pennsylvania, United States
- Vanderbilt Weight Loss Center, Nashville, Tennessee, United States
- Endocrine and Psychiatry Center, Houston, Texas, United States
- +6 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06747468 on ClinicalTrials.govOther trials for Disorder of carbohydrate metabolism
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07420998Effect of a Nutritional Product Containing Carob Extract on Carbohydrate Metabolism in Glucose-intolerant SubjectsUniversidad Católica San Antonio de Murcia
- RECRUITINGNCT07160816A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood SugarNovo Nordisk A/S
- RECRUITINGPHASE3NCT07076199A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesNovo Nordisk A/S
- RECRUITINGNANCT07150052Efficacy and Safety of an Artificial Intelligence Tool for Carbohydrate Counting (Tiabete) in Children and Adults With Type 1 Diabetes MellitusUniversity of Sao Paulo
- RECRUITINGNANCT06814171UBC Breakfast Study 2.0University of British Columbia
- RECRUITINGNANCT06837376Effects of Metabolic Testing Data and Education on Attitudes and Beliefs Related to Carbohydrate Intake in Adolescent Female AthletesPepsiCo Global R&D
- RECRUITINGNANCT06614101Study Enabling the Collection of Clinical Data Necessary for the Second Phase of Development of the Glycemic Measurement Device by Analysis of Exhaled AirUniversity Hospital, Toulouse
- RECRUITINGNANCT06700915A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and MetabolismUltimate International, Inc.